46123-83-5 Usage
General Description
2-(4-chlorobenzyl)guanidine is a chemical compound with the molecular formula C8H9ClN2. It is a guanidine derivative and is commonly used as an antihypertensive agent and an alpha-2 adrenergic agonist. It is also known to have antibacterial and antifungal properties, making it useful in the medical and pharmaceutical industries. Additionally, it has been studied for its potential use in treating neuropathic pain and as an adjunct treatment for opioid withdrawal. 2-(4-chlorobenzyl)guanidine is a white to off-white crystalline powder and is usually administered in the form of a tablet or a solution. Overall, 2-(4-chlorobenzyl)guanidine has a wide range of potential applications and is a versatile chemical with various therapeutic uses.
Check Digit Verification of cas no
The CAS Registry Mumber 46123-83-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,6,1,2 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 46123-83:
(7*4)+(6*6)+(5*1)+(4*2)+(3*3)+(2*8)+(1*3)=105
105 % 10 = 5
So 46123-83-5 is a valid CAS Registry Number.
46123-83-5Relevant articles and documents
Production of new amilorides as potent inhibitors of mitochondrial respiratory complex I
Murai, Masatoshi,Habu, Sayako,Murakami, Sonomi,Ito, Takeshi,Miyoshi, Hideto
, p. 1061 - 1066 (2015/10/05)
Amilorides, well-known inhibitors of Na+/H+ antiporters, have also shown to inhibit bacterial and mitochondrial NADH-quinone oxidoreductase (complex I). Since the membrane subunits ND2, ND4, and ND5 of bovine mitochondrial complex I
Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: A novel class of selective human A-FABP inhibitors
Ringom, Rune,Axen, Eva,Uppenberg, Jonas,Lundb?ck, Thomas,Rondahl, Lena,Barf, Tjeerd
, p. 4449 - 4452 (2007/10/03)
The synthesis and evaluation of novel human A-FABP inhibitors based on the 6-(trifluoromethyl)pyrimidine-4(1H)-one scaffold is described. Two series of compounds, bearing either an amino or carbon substituent in the 2-position of the pyrimidine ring were